Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 116436-10-3 | MDL No. : | MFCD11520466 |
Formula : | C9H10BrNO | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | HCSKOFDCUTVQKW-UHFFFAOYSA-N |
M.W : | 228.09 g/mol | Pubchem ID : | 14233594 |
Synonyms : |
|
Num. heavy atoms : | 12 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.22 |
Num. rotatable bonds : | 2 |
Num. H-bond acceptors : | 1.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 53.42 |
TPSA : | 29.1 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.36 cm/s |
Log Po/w (iLOGP) : | 2.23 |
Log Po/w (XLOGP3) : | 1.88 |
Log Po/w (WLOGP) : | 2.53 |
Log Po/w (MLOGP) : | 2.56 |
Log Po/w (SILICOS-IT) : | 2.52 |
Consensus Log Po/w : | 2.34 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -2.68 |
Solubility : | 0.48 mg/ml ; 0.00211 mol/l |
Class : | Soluble |
Log S (Ali) : | -2.11 |
Solubility : | 1.76 mg/ml ; 0.00771 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -4.03 |
Solubility : | 0.0212 mg/ml ; 0.0000929 mol/l |
Class : | Moderately soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.6 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P280-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302 | Packing Group: | N/A |
GHS Pictogram: |
![]() |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
[ 119416-26-1 ]
N-(4-Bromo-2,6-dimethylphenyl)acetamide
Similarity: 0.95
[ 116436-11-4 ]
N-(2-Bromo-6-methylphenyl)acetamide
Similarity: 0.89
[ 461413-87-6 ]
N-(4-Bromo-2-methylphenyl)propionamide
Similarity: 0.88
[ 13711-31-4 ]
N-(4-Bromo-2,5-dimethylphenyl)acetamide
Similarity: 0.88
[ 7147-52-6 ]
N-(5-Bromo-[1,1'-biphenyl]-2-yl)acetamide
Similarity: 0.88
[ 119416-26-1 ]
N-(4-Bromo-2,6-dimethylphenyl)acetamide
Similarity: 0.95
[ 116436-11-4 ]
N-(2-Bromo-6-methylphenyl)acetamide
Similarity: 0.89
[ 461413-87-6 ]
N-(4-Bromo-2-methylphenyl)propionamide
Similarity: 0.88
[ 13711-31-4 ]
N-(4-Bromo-2,5-dimethylphenyl)acetamide
Similarity: 0.88
[ 7147-52-6 ]
N-(5-Bromo-[1,1'-biphenyl]-2-yl)acetamide
Similarity: 0.88
[ 119416-26-1 ]
N-(4-Bromo-2,6-dimethylphenyl)acetamide
Similarity: 0.95
[ 116436-11-4 ]
N-(2-Bromo-6-methylphenyl)acetamide
Similarity: 0.89
[ 461413-87-6 ]
N-(4-Bromo-2-methylphenyl)propionamide
Similarity: 0.88
[ 13711-31-4 ]
N-(4-Bromo-2,5-dimethylphenyl)acetamide
Similarity: 0.88
[ 7147-52-6 ]
N-(5-Bromo-[1,1'-biphenyl]-2-yl)acetamide
Similarity: 0.88
[ 119416-26-1 ]
N-(4-Bromo-2,6-dimethylphenyl)acetamide
Similarity: 0.95
[ 116436-11-4 ]
N-(2-Bromo-6-methylphenyl)acetamide
Similarity: 0.89
[ 461413-87-6 ]
N-(4-Bromo-2-methylphenyl)propionamide
Similarity: 0.88
[ 13711-31-4 ]
N-(4-Bromo-2,5-dimethylphenyl)acetamide
Similarity: 0.88
[ 7147-52-6 ]
N-(5-Bromo-[1,1'-biphenyl]-2-yl)acetamide
Similarity: 0.88